Metta-Based Therapy for Chronic Depression: a Wait List Control Trial

Abstract

Objectives Current treatments for chronic depression have focused on reducing interpersonal problems and negative affect, but paid little attention to promoting prosocial motivation and positive affect. Following this treatment focus, the objective of the present study was to examine whether the combination of metta (Loving Kindness) group meditation and subsequent tailored individual therapy focusing on kindness towards oneself and others (metta-based therapy, MBT) shows greater improvements in depressive symptoms than a wait list control group in patients with chronic depression. Methods Forty-eight patients with DSM-5 persistent depressive disorder were randomly assigned to MBT or a wait list control condition. Outcome was assessed after group meditation, after subsequent individual therapy, and at 6-month follow-up. The primary outcome measure was an independent blind rating of depressive symptoms at post-test. Secondary outcome included changes in self-reported depression, behavioral activation, rumination, social functioning, mindfulness, compassion, and clinician-rated emotion regulation. Results Mixed-design analyses showed significant differences between MBT and WLC in changes from pre- to post-test in clinician-rated and self-rated depression, behavioral activation, rumination, social functioning, mindfulness, and emotion regulation. Most of the changes occurred during group meditation and were associated with large effect sizes. Improvements were maintained at 6-month follow-up. Conclusions The results provide preliminary support for the effectiveness of MBT in treating chronic depression. Trial Registration ISRCTN, ISRCTN97264476.

Videobasierte Online-Metta-Meditations-Therapie bei Depression: Eine Pilotstudie zur Bewertung von Akzeptanz und Machbarkeit

“…Anhedonie ist signifikant mit Symptomschwere, Störungsverlauf und Behandlungserfolg assoziiert [Morris et al, 2009;Winer et al, 2014;Ducasse et al, 2018;Dunn et al, 2019], weshalb eine Metta-basierte Behandlung bei akut chronisch depressiv Erkrankten vielversprechend erscheint. So hat sich die WFT im Rahmen einer randomisiert kontrollierten Studie als wirksamer Therapieansatz zur Reduktion depressiver Symptome und zur Steigerung von Verhaltensaktivierung, Mitgefühl, sozialem Funktionsniveau und Achtsamkeit erwiesen [Stangier et al, 2021].…”